Our Bridge2asia campaign provides a more direct connection for exporting high-quality bulk and retail-ready pharmaceuticals, produced in FDA-approved European and Asian laboratories, to approved distributors and wholesalers.

The complex American system intertwines source, dispensary, insurance, and rebates, which only serves to increase prices to the consumer:

Bridge2asia simplifies and expedites the process by providing direct sales to approved independent wholesalers and distributors, and independent pharmacies that buy in bulk: